EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Small Molecule‐Mediated Nrf2 Activation as a Neuroprotective Approach in Multiple Sclerosis

Arnav Borole iD, Kevin Boguszewski iD, Philip Furmanski, Nanjoo Suh iD

Drug Development Research · 2026-12 · 87 (8)

DOI: 10.1002/ddr.70406 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Development Research, online erschienen am 15.11.2026. Verfasst von Arnav Borole und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Multiple Sclerosis, Neuroprotective Agents. Die Arbeit nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIEHS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis is a chronic inflammatory autoimmune disease resulting in progressive demyelination of the central nervous system, leading to symptoms such as motor discoordination, cognitive deficits, and ocular dysfunction. Oxidative stress is a crucial component in the pathogenesis of multiple sclerosis, with reactive oxygen species contributing to myelin destruction, neuronal injury, and disruption of the blood‐brain barrier resulting in symptom progression. For this reason, reducing oxidative stress has gained attention as a promising mechanism of disease control. Nuclear factor erythroid‐2‐related factor‐2 (Nrf2) is a master regulator of the cellular antioxidant and anti‐inflammatory response throughout the body, including the central nervous system. Nrf2 functions as a transcription factor to activate the expression of genes involved in detoxification and antioxidant defense, thus playing a critical role in limiting neuronal oxidative damage resulting from multiple sclerosis. Since no curative treatments are currently available for multiple sclerosis, recognizing potential new drugs that target earlier stages of the disease may be a viable strategy to intervene in disease progression and improve quality of life for the patient. This review explores how Nrf2 is a promising target for intervention in multiple sclerosis and that many Nrf2 activators exhibit robust efficacy, highlighting their potential as novel agents for multiple sclerosis treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2Multiple SclerosisNeuroprotective AgentsHumansAnimalsOxidative Stress

Stichwörter der Autor:innen

Nrf2multiple sclerosisoxidative stress

Substanzen

NF-E2-Related Factor 2Neuroprotective AgentsNFE2L2 protein, human

Autor:innen und Institutionen

  • Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
  • Graduate Program of Pharmaceutical Sciences, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
  • Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, New Jersey, USA.

ORCID-Profile: Arnav Borole, Kevin Boguszewski, Nanjoo Suh

Förderung

  • NCI NIH HHS
  • NIEHS NIH HHS
  • National Institutes of Health

Zitieren

APA

Borole, A., Boguszewski, K., Furmanski, P., & Suh, N. (2026). Small Molecule‐Mediated Nrf2 Activation as a Neuroprotective Approach in Multiple Sclerosis. Drug Development Research, 87(8). https://doi.org/10.1002/ddr.70406

Vancouver

Borole A, Boguszewski K, Furmanski P, Suh N. Small Molecule‐Mediated Nrf2 Activation as a Neuroprotective Approach in Multiple Sclerosis. Drug Development Research. 2026;87(8). doi:10.1002/ddr.70406

BibTeX
@article{Borole2026,
  author = {Borole, Arnav and Boguszewski, Kevin and Furmanski, Philip and Suh, Nanjoo},
  title = {Small Molecule‐Mediated Nrf2 Activation as a Neuroprotective Approach in Multiple Sclerosis},
  journal = {Drug Development Research},
  year = {2026},
  volume = {87},
  number = {8},
  doi = {10.1002/ddr.70406}
}
Kostenlos starten →